Garnero P - Search Results

1

Collagen type II C-telopeptide fragments as an index of cartilage degradation.

Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. Christgau S, et al. Among authors: garnero p. Bone. 2001 Sep;29(3):209-15. doi: 10.1016/s8756-3282(01)00504-x. Bone. 2001. PMID: 11557363

2

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.

Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Garnero P, et al. J Bone Miner Res. 1995 Apr;10(4):641-9. doi: 10.1002/jbmr.5650100418. J Bone Miner Res. 1995. PMID: 7610936

3

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Garnero P, et al. J Clin Endocrinol Metab. 1994 Dec;79(6):1693-700. doi: 10.1210/jcem.79.6.7989477. J Clin Endocrinol Metab. 1994. PMID: 7989477 Clinical Trial.

4

Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.

Garnero P, Gineyts E, Riou JP, Delmas PD. Garnero P, et al. J Clin Endocrinol Metab. 1994 Sep;79(3):780-5. doi: 10.1210/jcem.79.3.8077361. J Clin Endocrinol Metab. 1994. PMID: 8077361

5

Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease.

Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. Delmas PD, et al. Among authors: garnero p. J Bone Miner Res. 1993 May;8(5):643-8. doi: 10.1002/jbmr.5650080516. J Bone Miner Res. 1993. PMID: 8511992

6

Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.

Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C. Bonde M, et al. Among authors: garnero p. J Bone Miner Res. 1997 Jul;12(7):1028-34. doi: 10.1359/jbmr.1997.12.7.1028. J Bone Miner Res. 1997. PMID: 9200001 Free article.

7

Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.

Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD. Garnero P, et al. J Bone Miner Res. 1997 Sep;12(9):1407-15. doi: 10.1359/jbmr.1997.12.9.1407. J Bone Miner Res. 1997. PMID: 9286756 Free article.

8

Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.

Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD. Garnero P, et al. Arthritis Rheum. 1998 Feb;41(2):354-60. doi: 10.1002/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5. Arthritis Rheum. 1998. PMID: 9485094 Clinical Trial.

9

Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products.

Garnero P, Jouvenne P, Buchs N, Delmas PD, Miossec P. Garnero P, et al. Bone. 1999 Apr;24(4):381-5. doi: 10.1016/s8756-3282(98)00193-8. Bone. 1999. PMID: 10221550

10

Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover.

Gineyts E, Cloos PA, Borel O, Grimaud L, Delmas PD, Garnero P. Gineyts E, et al. Among authors: garnero p. Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):481-5. Biochem J. 2000. PMID: 10642505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters